{"mainPropery":{"diseaseId":12059,"diseaseName":"GM3 synthase deficiency","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12059/gm3-synthase-deficiency","synonyms":["Infantile-onset symptomatic epilepsy syndrome - developmental stagnation - blindness","Epilepsy syndrome, infantile-onset symptomatic","Amish infantile epilepsy syndrome","ST3GAL5-CDG","Salt and pepper syndrome"],"synonyms-with-source":[{"name":"Infantile-onset symptomatic epilepsy syndrome - developmental stagnation - blindness","source":"Orphanet"},{"name":"Epilepsy syndrome, infantile-onset symptomatic","source":"OMIM"},{"name":"Amish infantile epilepsy syndrome","source":"Orphanet"},{"name":"ST3GAL5-CDG","source":"Orphanet"},{"name":"Salt and pepper syndrome","source":"OMIM"}],"identifiers":[{"identifierType":"OMIM","identifierId":"609056"},{"identifierType":"ORPHANET","identifierId":"171714"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":3250,"resourceName":"Citizens United for Research in Epilepsy","abbreviation":"CURE","address1":" 430 W. Erie","address2":"Suite 210","address3":"","address4":"","address5":"","city":"Chicago","state":"IL","zip":"60654   ","country":"United States","phone":"+1-312-255-1801","tty":"","tollFree":"","fax":"","email":"info@CUREepilepsy.org ","url":"https://www.cureepilepsy.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/609056' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/gm3-synthase-deficiency' target='_blank'>Genetics Home Reference (GHR)</a> contains information on GM3 synthase deficiency. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=171714' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:609056' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":10923,"questionText":"What is GM3 synthase deficiency?","answerText":"<strong>GM3 synthase deficiency</strong><strong>&nbsp;</strong>is a rare <a href=\"https://www.ucsfhealth.org/conditions/neurological_disorders/\" target=\"_blank\">neurological disorder</a>&nbsp;in which the brain does not develop normally. Symptoms of the disease begin within the first weeks or months of life and include difficulty feeding, irritability, vomiting, and seizures accompanied by loss of consciousness (<a href=\"https://medlineplus.gov/ency/article/000695.htm\" target=\"_blank\">grand mal seizures</a>). Vision and hearing loss, spots of darker skin color (<a href=\"http://www.aocd.org/?page=Hyperpigmentation\" target=\"_blank\">hyperpigmentation</a>), and intellectual and <a href=\"http://www.cdc.gov/ncbddd/developmentaldisabilities/facts.html\" target=\"_blank\">developmental delays</a> develop as the disease progresses.[11944] GM3 synthase deficiency is a <a href=\"https://rarediseases.info.nih.gov/gard/10307/congenital-disorders-of-glycosylation/resources/1\" target=\"_blank\">congenital disorder of glycosylation</a> and includes both cases described as Amish infantile epilepsy syndrome and cases described as salt &amp; pepper syndrome.<br />\r\n<br />\r\nGM3 synthase deficiency is caused by a <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>  in the <em><a href=\"https://ghr.nlm.nih.gov/gene/ST3GAL5\" target=\"_blank\">ST3GAL5</a></em> <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>  and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>  manner. The <em>ST3GAL5</em> gene tells the body to make an enzyme that supports <a href=\"http://lipidlibrary.aocs.org/Primer/content.cfm?ItemNumber=39329\" target=\"_blank\">gangliosides</a>, which are molecules that are important for brain development and function.[11944][11945][11946]<br />\r\n<br />\r\nGM3 synthase deficiency is suspected when a child presents with symptoms characteristic of the disease. Genetic testing confirms the diagnosis. Treatment is focused on relieving symptoms of the disease, which may include nutritional and feeding support and medications to lessen the severity of seizures. Although there is no cure for the condition, children with GM3 synthase deficiency have lived into early adulthood.[11945][11946]<br />","dateModified":"2016-08-03T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":10307,"relatedDiseaseName":"Congenital disorders of glycosylation","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":11303,"phenoTypeName":"Hearing impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9844,"phenoTypeName":"Microcephaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10648,"phenoTypeName":"Absent speech","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":13458,"phenoTypeName":"Bilateral tonic-clonic seizure","percentRanges":"-"},{"phenoTypeId":11795,"phenoTypeName":"Cerebral visual impairment","percentRanges":"-"},{"phenoTypeId":8726,"phenoTypeName":"Choreoathetosis","percentRanges":"-"},{"phenoTypeId":5154,"phenoTypeName":"Developmental regression","percentRanges":"-"},{"phenoTypeId":12150,"phenoTypeName":"Developmental stagnation at onset of seizures","percentRanges":"-"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","percentRanges":"-"},{"phenoTypeId":3410,"phenoTypeName":"Feeding difficulties in infancy","percentRanges":"-"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","percentRanges":"-"},{"phenoTypeId":11234,"phenoTypeName":"Global brain atrophy","percentRanges":"-"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","percentRanges":"-"},{"phenoTypeId":8313,"phenoTypeName":"Hypermelanotic macule","percentRanges":"-"},{"phenoTypeId":12585,"phenoTypeName":"Hyporeflexia of upper limbs","percentRanges":"-"},{"phenoTypeId":10038,"phenoTypeName":"Irritability","percentRanges":"-"},{"phenoTypeId":5171,"phenoTypeName":"Lower limb hyperreflexia","percentRanges":"-"},{"phenoTypeId":5110,"phenoTypeName":"Multifocal epileptiform discharges","percentRanges":"-"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","percentRanges":"-"},{"phenoTypeId":10639,"phenoTypeName":"Myoclonus","percentRanges":"-"},{"phenoTypeId":10124,"phenoTypeName":"Optic atrophy","percentRanges":"-"},{"phenoTypeId":13751,"phenoTypeName":"Status epilepticus","percentRanges":"-"},{"phenoTypeId":9162,"phenoTypeName":"Visual loss","percentRanges":"-"},{"phenoTypeId":13400,"phenoTypeName":"Vomiting","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"GM3_synthase_deficiency"}